Clinical Trial Update: Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of homoharringtonine with oral imatinib (Gleevec) in chronic, accelerated-phase, and blast-phase chronic myeloid leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Homoharringtonine (homoharringtonine)

Snippet

Sponsor: ChemGenex Pharmaceuticals | Conditions: Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated-Phase | Phase 2 | Status: TERMINATED | Results posted: 2015-01-15